Protein kinase C-u (PKC-u) translocates to the center of the immunological synapse, but the underlying mechanism and its importance in T cell activation are unknown. Here we found that the V3 domain of PKC-u was necessary and sufficient for localization to the immunological synapse mediated by association with the coreceptor CD28 and dependent on the kinase Lck. We identified a conserved proline-rich motif in V3 required for association with CD28 and immunological synapse localization. We found association with CD28 to be essential for PKC-u-mediated downstream signaling and the differentiation of T helper type 2
The induction of an immune response depends on effective communication between antigen-specific T cells and antigen-presenting cells (APCs). When a T cell expressing a cognate T cell antigen receptor (TCR) encounters an activated APC, both cells actively redistribute their receptors and ligands to the interface, creating a platform for effective signaling known as the immunological synapse. At steady state, the mature immunological synapse is composed of concentric rings with a central core (the central supramolecular activation cluster (cSMAC)) containing clusters of TCRs and costimulatory molecules, and a peripheral ring (the peripheral supramolecular activation cluster (pSMAC)) of adhesion molecules 1 . The engagement of these surface molecules triggers signaling cascades that result in the recruitment of intracellular proteins, including kinases, adaptors and cytoskeletal proteins, to the immunological synapse 2 . One of the most prominent proteins to be recruited to the immunological synapse after antigen stimulation is the kinase PKC-θ, whose localization is limited to the cSMAC 3, 4 .
PKC-θ is a member of the novel Ca 2+ -independent PKC subfamily expressed predominantly in T cells that has important and nonredundant roles in T cell activation and survival (but not in T cell development) [5] [6] [7] , which reflects its unique ability to activate the transcription factors NF-κB, AP-1 and NFAT 5, [8] [9] [10] [11] [12] . Studies of PKC-θ-deficient (Prkcq −/− ) mice have characterized the importance of PKC-θ in various disease models and have shown that its requirement in various forms of immunity is quite selective and not absolute. Thus, T helper type 2 (T H 2) responses to allergens or helminth infection 13, 14 and autoimmune diseases mediated by interleukin 17 (IL-17)-producing helper T cells (T H 17 cells) [15] [16] [17] require PKC-θ. In contrast, T H 1 immune responses to intracellular pathogens such as Leishmania major 13 , as well as antiviral effector and memory cytotoxic T lymphocyte responses, remain relatively intact in Prkcq −/− mice [18] [19] [20] [21] . Consistent with those in vivo findings, Prkcq −/− CD4 + T cells show impaired in vitro differentiation into the T H 2 and T H 17 lineages, whereas T H 1 differentiation is only slightly lower [13] [14] [15] . PKC-θ has been found to be required for allograft rejection and graft-versus-host disease but not for the graft-versus-leukemia response in mice 22 .
Although the antigen-induced localization of PKC-θ to the immunological synapse and, more specifically, to the cSMAC is well established 3, 4 , the molecular basis for this highly selective localization is not clear, nor is it known whether this localization is required for the signaling functions of PKC-θ in T cells. Here we identified and characterized the hinge region of PKC-θ, known as the V3 domain, as having a critical role in determining its localization to the immunological synapse and cSMAC through binding to the coreceptor CD28 and, consequently, dictating its signaling from the immunological synapse. Fine mapping further identified an evolutionarily conserved proline-rich motif required for association with CD28, localization to the cSMAC and PKC-θ-mediated functions. Notably, the isolated V3 domain of PKC-θ acted as a decoy in blocking PKC-θ-dependent functions, including T H 2 and T H 17 differentiation, but not T H 1 differentiation, and inflammation. Our findings indicate a unique signaling mode of CD28 and establish the molecular basis for the specialized localization and function of PKC-θ in antigen-stimulated T cells. 1 1 0 6 VOLUME 12 NUMBER 11 NOVEMBER 2011 nature immunology A r t i c l e s RESULTS Importance of the V3 domain for PKC-u function As a first step toward understanding the basis for unique antigeninduced PKC-θ localization to the immunological synapse and cSMAC, we compared the amino acid sequences of PKC-θ and PKC-δ, its closest relative (with 62% identity and 75% homology) in the newly identified, Ca 2+ -independent PKC subfamily ( Supplementary Fig. 1 ). However, unlike PKC-θ, PKC-δ does not translocate to the immunological synapse after interaction between T cells and APCs 3 . Sequence alignment showed substantial divergence between the V3 (hinge) domains of these two isoforms (amino acids ~291-378 of human PKC-θ; Supplementary Fig. 1 ), which suggested that this region might have a role in targeting PKC-θ to the immunological synapse. This region has not been linked before, to our knowledge, to the regulation of PKC-θ localization or function other than its general role as a flexible hinge that allows PKC proteins to undergo a conformational change from a resting state into an 'open' , active conformation 23 .
To determine if the V3 domain is required for the localization of PKC-θ to the immunological synapse, we constructed mutant PKC-θ with deletion of V3 (PKC-θ-∆V3). When retrovirally transduced into Prkcq −/− CD4 + T cells with transgenic expression of the ovalbumin (OVA)-specific OT-II TCR, wild-type PKC-θ localized to the center of the immunological synapse (that is, the cSMAC) after stimulation with APCs pulsed with OVA peptide (Fig. 1a,b) , as evident from its central localization relative to that of talin, a known pSMAC marker 4 . In contrast, PKC-θ-∆V3 did not translocate to the immunological synapse and instead remained largely cytosolic. Because V3 domain deletion could cause a gross conformational change, we next generated an exchange mutant in which we replaced the native V3 domain of PKC-θ with the corresponding domain of PKC-δ (PKC-θ+δV3). Similar to PKC-θ-∆V3 mutants, this mutant also failed to translocate to the immunological synapse and the cSMAC (Fig. 1a,b) . The localization of talin to the peripheral immunological synapse in T cells expressing both mutants indicated that the organization of a mature immunological synapse was not grossly impaired in the absence of wild-type PKC-θ. These data suggest that the unique V3 domain of PKC-θ is required for its selective localization to the immunological synapse and cSMAC.
The quality of T cell activation seems to correlate with the clustering of PKC-θ in the immunological synapse 4, 24 . However, direct evidence is missing that the localization of PKC-θ to the immunological synapse and cSMAC is essential for its downstream functions. Therefore, we investigated whether loss or replacement of the PKC-θ V3 domain impairs the activation of key transcription factors essential for productive T cell activation that are known targets of PKC-θ 5, [8] [9] [10] [11] [12] , specifically NF-κB, AP-1 and NFAT ( Fig. 1c) . Stimulation of cells transfected with empty vector with peptide-pulsed APCs consistently resulted in minimal stimulation of reporter genes (discussed below), which most probably reflected the weaker stimulus provided by peptide-pulsed APCs than by saturating concentrations of antibody to (anti-CD3) and anti-CD28, which are more commonly used in such reporter assays. T cells transfected with wild-type PKC-θ had significantly higher basal activity of a CD28 response element (RE/AP; Fig. 1c ) and NFAT ( Supplementary Fig. 2) , which was even greater after stimulation with peptide-pulsed APCs. However, the activation of these reporter genes was completely abrogated in T cells transfected with PKC-θ-∆V3 or PKC-θ+δV3 ( Fig. 1c and Supplementary Fig. 2) .
We further analyzed the ability of PKC-θ+δV3 to activate primary T cells by generating bone marrow chimeras in irradiated mice deficient in recombination-activating gene 1 (Rag1 −/− mice) reconstituted with Prkcq −/− bone marrow cells infected in vitro with bicistronic retroviruses expressing green fluorescent protein (GFP) and wild-type PKC-θ or PKC-θ+δV3. We analyzed the transduced (GFP + ) T cells 8 weeks later. CD4 + T cells reconstituted with wild-type PKC-θ and costimulated with anti-CD3 and anti-CD28 considerably upregulated their expression of both CD69 and CD25, two activation markers regulated by PKC-θ 6 ; however, the ability of PKC-θ+δV3 to induce the expression of CD69 or CD25 was ~50% lower (Fig. 1d,e ). The transduced cells had similar expression of both wild-type PKC-θ and PKC-θ+δV3 (Fig. 1e, bottom) . Furthermore, in contrast to CD4 + T cells reconstituted with wild-type PKC-θ, which proliferated and produced IL-2 in response to stimulation with anti-CD3 and anti-CD28 in a dose-dependent manner, T cells reconstituted with PKC-θ+δV3 failed to proliferate and produce IL-2 ( Fig. 1f,g) , similar to CD4 + T cells from Prkcq −/− mice or T cells from bone marrow chimeras reconstituted with empty-vector. These data establish that the V3 domain of PKC-θ is critical for the activation of the PKC-θdependent TCR-CD28 signaling pathways that are important for T cell activation and, furthermore, that this is a nonredundant function that cannot be replaced by the V3 domain of the closely related PKC-δ.
The PKC-u V3 domain interacts with CD28
We hypothesized that the importance of the PKC-θ V3 domain for the enzyme's localization to the immunological synapse and function reflects a critical association of the V3 domain with a ligand that recruits it to the immunological synapse. Given the reported colocalization of PKC-θ and CD28 in the immunological synapse 25, 26 and the phorbol ester-induced association between the two 26 , we investigated whether costimulation with anti-CD3 and anti-CD28 caused PKC-θ to associate with CD28. Indeed, PKC-θ immunoprecipitated together with CD28 from T cells stimulated with anti-CD3 and anti-CD28 ( Supplementary  Fig. 3a ). We observed maximal association after 5 min of costimulation, and this association decreased thereafter but was still present after up to 30 min of costimulation. To identify the PKC-θ region required for this interaction, we transfected the Jurkat human T lymphocyte cell line with a series of PKC-θ deletion mutants ( Supplementary Fig. 3b ).
After costimulation with anti-CD3 and anti-CD28, wild-type PKC-θ, as well as a mutant with deletion of the N-terminal C2 domain shown before to negatively regulate the activation of PKC-θ 27 , immunoprecipitated together with CD28 ( Supplementary Fig. 3c ). However, deletion of the V3 domain abolished this interaction. Deletion of both the C2 and C1a domains of PKC-θ resulted in less interaction but did not abolish it. We repeated this analysis with primary Prkcq −/− CD4 + T cells that we transduced with various retroviruses expressing PKC-θ or PKC-δ. The ∆V3 mutant ( Fig. 2a) , as well as the PKC-θ+δV3 mutant and wild-type PKC-δ ( Fig. 2a, middle) , did not immunoprecipitate together with CD28. Thus, the V3 domain of PKC-θ is required for the inducible interaction with CD28. Moreover, the V3 domain was sufficient for this interaction, as Myc-tagged V3 transduced via retrovirus immunoprecipitated together with endogenous CD28 from Prkcq −/− primary CD4 + T cells ( Fig. 2a, right) . The V3 domain also localized together with cyan fluorescent protein-tagged CD28 in the immunological synapse of cotransfected Jurkat T cells ( Fig. 2b) . Therefore, the PKC-θ V3 domain is necessary and sufficient for the CD3-CD28-induced interaction of PKC-θ with CD28.
A proline-rich V3 motif is critical for recruitment of PKC-u Inspection of the PKC-θ V3 domain showed a proline-rich motif that corresponded to amino acids 328-336 of human PKC-θ (ARPPCLPTP; proline residues underlined). This motif was phylogenetically conserved, especially at the two internal proline residues, in PKC-θ enzymes from many species (Supplementary Fig. 4 ) but was absent from the hinge domains of other PKC enzymes. Because proline-rich motifs are known to bind Src homology 3 (SH3) and Trp-Trp (WW) domains 28 , we investigated whether this motif is important for the localization and function of PKC-θ by inserting it into the V3 domain of PKC-δ (which does not translocate to the immunological synapse). Stimulation of Prkcq −/− OT-II T cells with conjugated OVA-pulsed APCs induced translocation of transduced wild-type PKC-θ and endogenous talin to the cSMAC and the pSMAC, respectively, whereas transduced wild-type PKC-δ did not translocate to the immunological synapse ( Fig. 3a,b) . However, when we introduced the proline-rich motif into PKC-δ (PKC-δ+θPR), it had localization to the immunological synapse similar to that of wild-type PKC-θ, which suggested that the proline-rich motif in PKC-θ V3 can mediate localization to the immunological synapse and cSMAC. A r t i c l e s Similar to wild-type PKC-θ, but unlike wild-type PKC-δ, PKC-δ+θPR also immunoprecipitated together with CD28 in transduced Prkcq −/− CD4 + T cells costimulated with anti-CD3 and anti-CD28 ( Fig. 3c, left) . This association was dependent on T cell stimulation, as we did not observe it in similar immunoprecipitates from unstimulated T cells ( Fig. 3c, right) . Similarly, the PKC-δ+θPR mutant was able to stimulate the activity of reporters for RE/AP ( Fig. 3d) and NFAT ( Supplementary Fig. 5 ) in a stimulated moth cytochrome c (MCC)-specific T cell hybridoma to a degree approaching that of wild-type PKC-θ (~70-80%) but significantly higher than that of wild-type PKC-δ. Therefore, the proline-rich motif in PKC-θ V3 is required for the inducible association with CD28 and the activation of PKC-θ-dependent signaling.
To determine which proline residues in the proline-rich motif are important for localization to the immunological synapse, association with CD28 and reporter activation, we substituted the two external proline residues (P330-6A), two internal proline residues (P331-4A) or all four proline residues (4PA) with alanine in the PKC-θ proline-rich motif (amino acids 330-336, where the numbering refers to residues of complete human PKC-θ, with the sequence PPXXPXP, where 'X' is any amino acid). Localization of the transduced P330-6A PKC-θ mutant to the immunological synapse and cSMAC in OVA-stimulated Prkcq −/− OT-II T cells was intact and was similar to that of wild-type PKC-θ ( Fig. 4a  and Supplementary Fig. 6) . In contrast, the P331-4A and 4PA PKC-θ mutants failed to localize to the immunological synapse and remained largely cytosolic, which suggested that Pro331 and Pro334 are essential for the antigen-induced recruitment of PKC-θ to the immunological synapse. We obtained similar results when we analyzed these PKC-θ mutants for their ability to associate with CD28 and activate reporter genes. Thus, the P331-4A and 4PA mutants, but not the P330-6A mutant, did not coimmunoprecipitate with CD28 ( Fig. 4b) and were less able to activate reporters for RE/AP (Fig. 4c) or NFAT (Supplementary Fig. 7) .
We further established the importance of the proline-rich (Pro-X-X-Pro) motif in CD4 + T cells from bone marrow chimeras on the Prkcq −/− background reconstituted with the proline mutants studied above. Unstimulated T cells from mice reconstituted with PKC-θ had very low expression of CD69 and CD25 (Fig. 4d) . T cells reconstituted with wild-type PKC-θ or P330-6A and stimulated with anti-CD3 and anti-CD28 considerably upregulated their expression of these activation markers. However, in cells reconstituted with the P331-4A or 4PA mutant, upregulation of CD69 and CD25 was ~40-50% lower (Fig. 4d,e ). We obtained parallel results when we measured proliferation ( Fig. 4e) and IL-2 production (Fig. 4f) in the same cells, although CD4 + T cells expressing the P331-4A or 4PA mutant did produce some IL-2 (Fig. 4f) . The transduced T cells had similar expression of the wild-type or mutant PKC-θ proteins (data not shown and Fig. 1e ). Therefore, activation of primary T cells also critically depended on the Pro331 and Pro334 residues of PKC-θ.
The kinase Lck mediates the PKC-u-CD28 interaction
The identification of the Pro-X-X-Pro motif, a potential SH3-binding motif, in the PKC-θ V3 domain as being essential for association with CD28 was notable because our mapping analysis of the CD28 cytoplasmic tail showed that a C-terminal proline-rich motif in mouse CD28 (amino acids 206-209 (Pro-Tyr-Ala-Pro)) was required for the CD28-PKC-θ interaction (data not shown). That is the same CD28 motif required for colocalization of PKC-θ-CD28 to the cSMAC, for stabilization of IL-2 mRNA and for the reorganization of lipid rafts 26, [29] [30] [31] , as well as for PKC-θ-dependent T H 2-and T H 17-mediated inflammatory responses [13] [14] [15] [16] [17] 21 . Because direct association between the proline-rich motifs in PKC-θ and CD28 is unlikely, we surmised that this interaction requires an intermediary molecule, with the kinase Lck being a strong candidate. Indeed, we found that the interaction between CD28 and V3 was absent in Lck-deficient Jurkat (JCam1.6) cells and was restored after transfection of an expression plasmid for wild-type Lck, which was also included in the V3-CD28 complex (Fig. 5) . The V3 domain associated with Lck in which the Src homology 2 (SH2) domain was inactivated, but CD28 was not present in this complex. When we reconstituted JCam1.6 cells with Lck in which SH3 was inactivated, PKC-θ V3 failed to precipitate together with CD28 or Lck (Fig. 5) . These findings suggested that Lck mediates the interaction between PKC-θ and CD28, with its SH3 domain binding the proline-rich motif in PKC-θ V3 and its SH2 domain binding phosphorylated Tyr207 in the CD28 motif at amino acids 206-209 (Pro-Tyr-Ala-Pro) 30, 32 . This mode of a tri-partite interaction (Supplementary Fig. 8 ) was consistent with findings that the SH2 domain of Lck has a much higher affinity than the SH3 domain for the phosphorylated Pro-Tyr-Ala-Pro motif of CD28 (ref. 33 ) and, conversely, that in stimulated T cells, the Lck SH3 domain is considerably more effective than the SH2 domain in binding PKC-θ 34 .
Ectopic expression of V3 interferes with T cell activation
Given the critical role of the V3 domain in the association of PKC-θ with CD28, localization to the immunological synapse and T cell activation, we investigated whether ectopic expression of the isolated V3 domain would interfere with the localization and function of PKC-θ by functioning as a CD28-associated 'decoy' (Fig. 2a, right) and sequestering endogenous PKC-θ from CD28 and the immunological synapse. We infected OT-II CD4 + T cells with a bicistronic retrovirus expressing GFP and Myc-tagged V3 alone and examined the localization of the transduced V3 protein and endogenous PKC-θ after stimulation with OVA. The V3 domain translocated to the immunological synapse, but endogenous PKC-θ was sequestered from the immunological synapse, and we found it mostly in the cytoplasm (Fig. 6a,b) . However, when we transduced cells with a mutant V3 domain in which all four proline residues were replaced by alanine or a V3 domain with deletion of the entire proline-rich motif, they did not localize in the immunological synapse and, moreover, they did not interfere with the localization of endogenous PKC-θ to the immunological synapse ( Fig. 6a,b) . We next studied the effects of V3 on the activation of reporter genes. As expected, expression of wild-type PKC-θ alone resulted in much more antigen-induced activity of reporter genes for both RE/AP ( Fig. 6c) and NFAT (Supplementary Fig. 9 ) than that in control transfectants. Expression of the V3 domain alone did not activate these reporters. However, coexpression of the V3 domain together with wild-type PKC-θ resulted in dose-dependent inhibition of the activity of the PKC-θ-dependent reporter gene. This inhibitory activity was eliminated when the critical proline-rich motif was altered or deleted ( Fig. 6c and Supplementary Fig. 9 ), which resulted in intact PKC-θ-induced reporter activity.
T H 2 and T H 17 immune responses are compromised in Prkcq −/− mice, whereas the T H 1 response remains relatively intact [13] [14] [15] . Therefore, we determined whether ectopic V3 expression would similarly inhibit helper T cell differentiation. We infected preactivated C57BL/6 (B6) CD4 + T cells with retrovirus expressing wild-type or mutant V3 domains and cultured the cells in vitro under T H 1, T H 2 or T H 17 differentiation conditions. Consistent with published findings [13] [14] [15] , differentiation into the T H 1 lineage was unaffected by any of the ectopically expressed V3 vectors. In contrast, the non-mutant V3 domain inhibited T H 17 and T H 2 differentiation by ~75%. This A r t i c l e s (~60-75%, for T H 2) when the protein-rich motif was altered or deleted (Fig. 6d) . Hence, the V3 domain can act as a decoy in blocking the localization of endogenous PKC-θ to the immunological synapse and thus attenuate its associated signaling and helper T cell differentiation.
PKC-u V3 inhibits T H 2-but not T H 1-mediated airway inflammation
We further analyzed the effect of PKC-θ V3 in vivo in an airway inflammation model using a T cell adoptive-transfer system. Mice that received OT-II T H 2 cells transduced with an empty vector developed an inflammatory response much larger than that of PBS-challenged control mice, as shown by the greater number of infiltrating leukocytes in the bronchoalveolar lavage fluid from mice that received OT-II T H 2 cells ( Fig. 7a) and their augmented expression of the signature T H 2 cytokines IL-4 ( Fig. 7b) and IL-5 (Fig. 7c) . The introduction of V3 into the transferred T H 2 cells ameliorated the disease by diminishing the amount of infiltrating cells and T H 2 cytokines to basal amounts ( Fig. 7a-c) . However, expression of the V3 domain with deletion of the proline-rich motif failed to inhibit the inflammatory response. The 4PA mutant partially 'rescued' the inhibition, most probably because the surrounding amino acid residues in addition to the critical proline residues also contribute to the regulatory function of the V3 domain. Adoptive transfer of transduced T H 1 effector cells similarly induced lung inflammation manifested by leukocyte infiltration (Fig. 7d) and higher expression of interferon-γ (Fig. 7e) . The native V3 domain (as well as its mutant variants) did not inhibit the inflammatory response ( Fig. 7d,e) , consistent with the fact that T H 1-mediated lung inflammation is relatively independent of PKC-θ [13] [14] [15] . Thus, the V3 domain of PKC-θ can also function in vivo in a dominant-negative manner to block PKC-θ-dependent inflammation.
DISCUSSION

PKC-θ is a critical mediator of TCR-CD28 cosignaling in T cells.
Although the catalytic activity of PKC-θ is undoubtedly required for its downstream signaling functions, its localization to the immunological synapse 3 and lipid rafts 35 , which is mediated by its regulatory region, is also critical. However, despite circumstantial evidence on this subject 4, 36 , the relationship between the localization of PKC-θ to the cSMAC and its signaling functions, and whether the former is required for the latter, are not known, nor have the structural determinants that dictate this unique localization been identified. Here, we have shown that the V3 (hinge) domain of PKC-θ and, specifically, a proline-rich motif in V3, were required for this localization through its physical association with CD28 and, consequently, for PKC-θ-dependent T cell activation and T H 2-or T H 17-mediated inflammation. This represents direct evidence that the localization of PKC-θ to the cSMAC and its ability to activate downstream targets are functionally linked, with both residing in a defined structural motif. The signaling events associated with CD28 are not entirely understood, and it remains controversial whether CD28 induces unique signals or simply amplifies TCR signals 37, 38 . Hence, our finding of an inducible association between PKC-θ and CD28 is notable, as it indicates a previously unidentified, CD28specific signaling module that is not shared with TCR signals per se.
Published studies have circumstantially linked the localization of PKC-θ to the immunological synapse and its function to CD28. First, efficient PKC-θ-mediated activation of transcription factors depends on CD28 costimulation 8, 10 . Second, CD28 is necessary for the localization of PKC-θ to the cSMAC 36 , and this requirement has been mapped to a C-terminal Pro-Tyr-Ala-Pro-Pro motif starting at Pro206 in CD28 (ref. 39 ). Third, the colocalization of PKC-θ and CD28 to immunological-synapse-resident microclusters has been documented 25, 26 . Furthermore, in the mature immunological synapse, PKC-θ localizes together with CD28 in a newly defined peripheral subdomain of the cSMAC in a manner dependent on the same Pro-Tyr-Ala-Pro-Pro motif starting at Pro206 and immunoprecipitates together with CD28 in T cells stimulated with phorbol ester 26 . Our results here have established that this association was also induced by physiological stimulation with peptide-pulsed APCs and was dependent on a highly conserved proline-rich motif present in the V3 domain of PKC-θ but not in other PKC proteins. This unique motif defines a newly identified function of PKC-θ V3: costimulationdependent recruitment of the enzyme to the immunological synapse.
However, the requirement for the proline-rich motif was not absolute, as PKC-θ with mutant proline residues retained the ability to partially induce CD69 and CD25 upregulation. That probably reflected the fact that some aspects of T cell activation, such as Ca 2+ signaling 12 and CD69 upregulation, are only partially dependent on PKC-θ. Indeed, although PKC-θ has a role in CD69 upregulation 40 , CD69 expression is also strongly dependent on signaling by the GTPase Ras 41 .
As there is no known precedent for direct interaction between two proline-rich motifs, our finding that proline-rich motifs in both PKC-θ and CD28 were required for their interaction led us to postulate that an intermediary protein mediates this interaction. Published studies 30, 32 and our results here support the idea that Lck mediates this interaction through two distinct domains, with its SH2 and SH3 domains binding the phosphorylated motif at amino acids 206-209 (Pro-Tyr-Ala-Pro) of CD28 or the motif at amino acids 331-334 (Pro-X-X-Pro) in PKC-θ V3, respectively. This idea is consistent with the reported differences between the SH2 and SH3 domains of Lck in the efficiency of their binding to phosphorylated CD28 relative to their binding to PKC-θ 33, 34 . However, this model does not exclude the possibility that some other protein(s) act(s) as a bridge between CD28 and PKC-θ.
The importance of the V3 domain in targeting PKC-θ to CD28 and the immunological synapse is not inconsistent with the established importance of the C1 domain in recruiting PKC-θ to the plasma membrane or the immunological synapse. The PKC-θ C1 domain is reported to localize to the center of the immunological synapse 42 (although that study did not formally distinguish between the cSMAC and the pSMAC), which probably reflects the substantial accumulation of diacylglycerol (DAG), the PKC-mobilizing second messenger, at the immunological synapse. However, accumulation of DAG does not sufficiently explain the unique localization of PKC-θ to the cSMAC, as other PKC proteins that contain a functional DAGbinding C1 domain do not stably localize to the immunological synapse. Hence, there must be some other PKC-θ-specific feature that is responsible for its localization to the immunological synapse and cSMAC. We propose that the V3 domain, through its CD28 binding, is responsible for this highly selective, sustained and high-stoichiometry 3 localization of PKC-θ after the initial binding of the C1 domain to membrane DAG, an event that by itself may be highly dynamic and of low stoichiometry. Indeed, PKC-θ-∆V3, despite containing an intact C1 domain, showed cytosolic localization in stimulated T cells. This stable, long-term recruitment to the cSMAC allows PKC-θ to mediate its functions. In contrast, other PKC proteins that contain a functional C1 domain, such as the PKC-θ-related PKC-δ, which has an affinity for DAG similar to that of PKC-θ 27, 43 , may also localize at DAG-rich membrane sites but will fail to activate sustained signaling because of transient low-stoichiometry recruitment to the membrane and/or substrate specificity distinct from those of PKC-θ. In support of that idea, the C1 domain of PKC-θ localizes only transiently at the immunological synapse, whereas the localization of full-length PKC-θ to the immunological synapse is prolonged and stable 44 . Similarly, protein kinase D, which also contains a DAG-binding C1 domain, translocates transiently to the T cell immunological synapse 42 . In addition to the physical PKC-θ-CD28 association reported here, other regulatory events that may contribute to the selective localization of PKC-θ to the immunological synapse and cSMAC and its functions include its tyrosine phosphorylation in the N-terminal C2 domain, which relieves C2-mediated negative regulation 10, 27, 34 , autophosphorylation at Thr219 in the C1 domain 45 and/or specific C1 domain-mediated protein-protein interactions 46 .
Given the requirement of PKC-θ in T H 2-and T H 17-mediated inflammation and graft-versus-host disease but not in T H 1 antiviral or graft-versus-leukemia responses, PKC-θ is a likely drug target for a plethora of diseases. Small-molecule selective inhibitors of the catalytic activity of PKC-θ have been reported 47 . However, the catalytic domains of PKC proteins are highly conserved and, furthermore, kinase inhibitors generally suffer from a lack of sufficient specificity and hence have potential toxic side effects. Our report of a new approach with which to attenuate the function of PKC-θ by blocking its obligatory interaction with CD28 suggests that such blockade could serve as a basis for the development of new therapeutic agents that would selectively suppress undesired T cell-mediated inflammation while at the same time preserving desired immunity, such as antiviral responses.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
